Biogen Receives European Commission Approval For Zurzuvae

RefinitivMeno di 1 minuto di lettura

Biogen Inc BIIB:

BIOGEN RECEIVES EUROPEAN COMMISSION APPROVAL FOR ZURZUVAE® (ZURANOLONE), THE FIRST AND ONLY TREATMENT APPROVED FOR WOMEN WITH POSTPARTUM DEPRESSION IN EUROPE

© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html

Accedi o crea un account gratuito per leggere queste notizie